{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:12:53Z","timestamp":1793391173627,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI16\/00151"],"award-info":[{"award-number":["PI16\/00151"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajog.2024.10.055","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T11:59:35Z","timestamp":1730980775000},"page":"552.e1-552.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment of early-onset fetal growth restriction with low molecular weight heparin does not prolong gestation: a randomized clinical trial"],"prefix":"10.1016","volume":"232","author":[{"given":"Alba","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Peguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Meler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Camprub\u00ed-Camprub\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Gomez-Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Oros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ib\u00e1\u00f1ez-Burillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Schoorlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narc\u00eds","family":"Masoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolors","family":"T\u00e0ssies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4403-1274","authenticated-orcid":false,"given":"Francesc","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0069-7640","authenticated-orcid":false,"given":"Edurne","family":"Mazarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.10.055_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000357592","article-title":"Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol","volume":"36","author":"Figueras","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2024.10.055_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.AOG.0000253215.79121.75","article-title":"Predictors of neonatal outcome in early-onset placental dysfunction","volume":"109","author":"Baschat","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.301.6761.1111","article-title":"The fetal and infant origins of adult disease","volume":"301","author":"Barker","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.10.055_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/1471-0528.15590","article-title":"Achieving orphan designation for placental insufficiency: annual incidence estimations in Europe","volume":"126","author":"Spencer","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.10.055_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-2-53","article-title":"The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia","volume":"2","author":"Fisher","year":"2004","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.055_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.semperi.2007.05.002","article-title":"Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies","volume":"31","author":"Hossain","year":"2007","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2024.10.055_bib7","doi-asserted-by":"crossref","first-page":"561.e1","DOI":"10.1016\/j.ajog.2010.01.012","article-title":"Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction","volume":"202","author":"Kovo","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/uog.20350","article-title":"Distinctive patterns of placental lesions in pre-eclampsia vs small-for-gestational age and their association with fetoplacental Doppler","volume":"54","author":"Paules","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/jmf.11.6.362.367","article-title":"Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia","volume":"11","author":"Chaiworapongsa","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2024.10.055_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.0960-7692.2001.00590.x","article-title":"Monitoring of fetuses with intrauterine growth restriction: a longitudinal study","volume":"18","author":"Hecher","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib11","doi-asserted-by":"crossref","first-page":"F14","DOI":"10.1136\/adc.2009.164533","article-title":"The PREM score: a graphical tool for predicting survival in very preterm births","volume":"95","author":"Cole","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2024.10.055_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajog.2021.11.1357","article-title":"Clinical Opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach","volume":"226","author":"Lees","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib13","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012)","volume":"223","author":"Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2015.11.026","article-title":"Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function","volume":"137","author":"Shomer","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2024.10.055_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/HYPERTENSIONAHA.113.01494","article-title":"Microvesicles of women with gestational hypertension and preeclampsia affect human trophoblast fate and endothelial function","volume":"62","author":"Shomer","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.10.055_bib16","doi-asserted-by":"crossref","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","volume":"226","author":"Cruz-Lemini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1515\/jpme.1990.18.3.165","article-title":"Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses","volume":"18","author":"Arduini","year":"1990","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajog.2024.10.055_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9378(85)90298-4","article-title":"Estimation of fetal weight with the use of head, body, and femur measurements\u2013a prospective study","volume":"151","author":"Hadlock","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejogrb.2006.12.015","article-title":"Customized birthweight standards for a Spanish population","volume":"136","author":"Figueras","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.055_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"G\u00f3mez","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2024.10.055_bib23","series-title":"Thrombosis and embolism during pregnancy and the puerperium, reducing the risk (Green-top Guideline No. 37a)","year":"2015"},{"key":"10.1016\/j.ajog.2024.10.055_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020501","article-title":"Study protocol for a randomized controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP)","volume":"8","author":"Mazarico","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2024.10.055_bib25","first-page":"355","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility triasl","volume":"24","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.10.055_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1471-0528.1975.tb00710.x","article-title":"A critical evaluation of sonar \u201ccrown-rump length\u201d measurements","volume":"82","author":"Robinson","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.12371","article-title":"ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics","volume":"41","author":"Bhide","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2024.10.055_bib31","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"2013","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2024.10.055_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S1701-2163(16)34300-6","article-title":"Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis","volume":"31","author":"Bujold","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2024.10.055_bib33","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.10.055_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2018.08.006","article-title":"Tinzaparin for the treatment of foetal growth retardation: an open-labelled randomized clinical trial","volume":"170","author":"Hansen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2024.10.055_bib35","article-title":"Therapeutic role of enoxaparin in intra-uterine growth restriction: a randomized clinical trial","volume":"50","author":"Shirazi","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.055_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/14767050903443459","article-title":"Heparin for patients with growth restricted fetus: a prospective randomized controlled trial","volume":"23","author":"Yu","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2024.10.055_bib37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1538-7836.2011.04407.x","article-title":"Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial","volume":"9","author":"Kingdom","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajog.2024.10.055_bib38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.placenta.2014.07.010","article-title":"Unfractionated heparin and placental pathology in high-risk pregnancies: secondary analysis of a pilot randomized controlled trial","volume":"35","author":"D\u2019Souza","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2024.10.055_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/aogs.13730","article-title":"Figueras. Heparin therapy in placental insufficiency: systematic review and meta-analysis","volume":"99","author":"Mazarico","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2024.10.055_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib41","first-page":"577","article-title":"Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers","volume":"40","author":"Azizi","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2024.10.055_bib42","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bpobgyn.2018.02.007","article-title":"Prophylaxis and treatment of fetal growth restriction","volume":"49","author":"Nawathe","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.10.055_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/14767050903300969","article-title":"Fetal Gender and pregnancy outcomes","volume":"23","author":"Melamed","year":"2010","journal-title":"J.J Matern Fetal Neonatal Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782401127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293782401127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:38:37Z","timestamp":1762079917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293782401127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S000293782401127X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.10.055","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of early-onset fetal growth restriction with low molecular weight heparin does not prolong gestation: a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.10.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}